Zoom In on Dementia & Alzheimer’s
Join us for conversations with world-class expert scientists about groundbreaking research, innovative treatments, and practical advice for managing Alzheimer’s disease and other types of dementia. Each session includes a live Q&A where you can ask your questions directly to the experts.
Zoom In on Dementia & Alzheimer’s is a live, interactive monthly series presented by Alzheimer’s Disease Research, a BrightFocus Foundation program.
Whether you’ve been diagnosed with Alzheimer’s, are a caregiver for someone with the disease, or are simply interested in learning more, Zoom In on Dementia & Alzheimer’s offers essential information to help you navigate this challenging condition.
Upcoming Zoom In on Dementia & Alzheimer’s Episodes
Treatments for Alzheimer’s Agitation
Thursday, June 25, 2026, 1:00 pm ET
Featuring:
TBD
Catch Up
Missed an Episode?
Therapeutic TV for Alzheimer’s: What the Research Shows
In this episode, Allyson Schrier shares how research following her experience caring for her husband with dementia led her to create a streaming service designed to calm, engage, and support people living with memory loss.
The SPRING Trial: Targeting Gum Bacteria in Alzheimer’s
Dr. Michael J. Detke of Lighthouse Pharma explains the SPRING clinical trial and how the investigational oral drug LHP588 is being studied to reduce bacteria-related brain damage.
Is It Alzheimer’s? Recognizing Early Signs & Symptoms
Behavioral neurologist Dr. Sharon Cohen explains the early signs and symptoms of Alzheimer’s disease, medical conditions that can mimic dementia, and how to start a conversation with your doctor.
Alzheimer’s Clinical Trials 2026: An Insider’s Look with Dr. Jeffrey Cummings
Join Dr. Jeffrey Cummings as he shares an insider’s overview of the evolving Alzheimer’s treatment development pipeline.
Understanding Your APOE Status: Genetics and Alzheimer’s Risk
About 25% of people carry one copy of the APOE4 gene, the strongest genetic risk factor for developing Alzheimer’s. Dr. Eric M. Reiman explains what genetic testing can—and cannot—tell you, including why APOE4 signals increased risk but does not mean a definite Alzheimer’s diagnosis.
Leqembi and Kisunla: Your Questions Answered
A leading neurologist answers your most common questions about what Leqembi and Kisunla can realistically do, including effectiveness, safety, eligibility, infusion logistics, cost, and access.
The AHEAD Study: Can Alzheimer’s Be Prevented or Slowed Before Symptoms Begin?
Join Dr. Joshua Grill as he shares details about the AHEAD Study.
The Next Generation of Alzheimer’s Treatments
Behavioral neurologist Dr. Marwan Sabbagh explains emerging Alzheimer’s therapeutics now in late-stage clinical development.
The Gut Microbiome and Alzheimer’s Disease: Understanding the Connection
Join Dr. Beau Ances of Washington University in St. Louis to learn about the emerging science linking gut health and brain health.
Zoom In on Dementia & Alzheimer’s is supported in part through sponsorships from:
